Exelixis (EXEL) stock forecast for 2022

The forecast has been updated: October 3, 2022 5:59


Exelixis stock price online today

Analyst Target Price

27.46

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Exelixis stock stock today? What is the projected target price level for 2022? How much will it cost in 2022? Exelixis stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2022.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $27.46 target price for Exelixis stock stock.

Today 200 Day Moving Average is the resistance level (19.74 $).

50 Day Moving Average is the resistance level (18.69 $).




EXEL Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Nov 19.06 17.84 20.35 12.31 %
Dec 19.85 18.90 21.05 10.19 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Exelixis stock.


Exelixis overview

Exelixis Address

1851 HARBOR BAY PARKWAY, ALAMEDA, CA, US

Market Capitalization

5 046 326 000 $

EBITDA

351 215 000

PE Ratio

18.67

PEG Ratio

0.317

Dividend Per Share

0

Dividend Yield

0

EPS

0.84

Quarterly Earnings Growth YOY

-0.267

Quarterly Revenue Growth YOY

0.089

Trailing PE

18.67

Forward PE

10.63

EV To Revenue

2.395

EV To EBITDA

10.6

52 Week High

23.4

52 Week Low

15.5

50 Day Moving Average

18.69

200 Day Moving Average

19.74

Shares Outstanding

321832000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Exelixis stock forecast for this year


Exelixis stock forecast for Nov 2022.
Estimated Average Forecasted Exelixis Price: 19.06. Positive monthly dynamics of the instrument is expected with 12.309% volatility is expected.

Pessimistic forecast: 17.84

Optimistic: 20.35


Exelixis stock forecast for Dec 2022.
Estimated Average Forecasted Exelixis Price: 19.85. Positive monthly dynamics of the instrument is expected with 10.186% volatility is expected.

Pessimistic forecast: 18.90

Optimistic: 21.05



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 103.38 (05.10.2022) 0.29 %
AbbVie Inc.
ABBV 143.33 (05.10.2022) 0.94 %
Aeterna Zentaris Inc.
AEZS 3.9701 (05.10.2022) -1.12 %
Allakos Inc.
ALLK 6.72 (05.10.2022) -0.30 %
Allogene Therapeutics, Inc.
ALLO 10.78 (05.10.2022) -2.00 %
Amgen Inc.
AMGN 233.82 (05.10.2022) 0.34 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 4.11 (05.10.2022) -2.61 %
Aurora Cannabis Inc.
ACB 1.24 (05.10.2022) -3.13 %
Becton Dickinson and Company
BDX 236.83 (05.10.2022) -0.06 %
Biogen Inc.
BIIB 261.69 (05.10.2022) -2.15 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 12.25 (05.10.2022) 47.59 %
BioNTech SE
BNTX 137.19 (05.10.2022) -0.28 %
bluebird bio, Inc.
BLUE 6.98 (05.10.2022) 2.80 %
Boston Scientific Corp.
BSX 41.3 (05.10.2022) 0.66 %
Bristol-Myers Squibb Company
BMY 71.45 (05.10.2022) 0.34 %
Canopy Growth Corp.
CGC 3.07 (05.10.2022) -2.23 %
Castle Biosciences, Inc.
CSTL 29.16 (05.10.2022) -2.80 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 20.84 (05.10.2022) -2.71 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 13.24 (05.10.2022) 3.44 %
Gilead Sciences, Inc.
GILD 65.45 (05.10.2022) 0.21 %
GlaxoSmithKline plc
GSK 30.41 (05.10.2022) -0.98 %
GoodRx Holdings, Inc.
GDRX 5.06 (05.10.2022) -4.89 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 69.5 (05.10.2022) -0.09 %
Inovio Pharmaceuticals, Inc.
INO 1.79 (05.10.2022) -2.19 %
Johnson & Johnson
JNJ 165.11 (05.10.2022) -0.31 %
Medtronic plc.
MDT 85.05 (05.10.2022) 0.65 %
Merck & Co., Inc.
MRK 88.39 (05.10.2022) 0.00 %
Moderna, Inc.
MRNA 125.62 (05.10.2022) -0.04 %
Novartis AG
NVS 77.37 (05.10.2022) -1.10 %
Novavax, Inc.
NVAX 18.7 (05.10.2022) -3.61 %
ObsEva SA
OBSV 0.1778 (05.10.2022) 4.71 %
OrganiGram Holdings Inc.
OGI 0.9049 (05.10.2022) -2.33 %
Pfizer Inc.
PFE 44.12 (05.10.2022) -0.76 %
Regeneron Pharmaceuticals, Inc.
REGN 745.68 (05.10.2022) 0.83 %
Sanofi
SNY 39.82 (05.10.2022) -0.75 %
Schrodinger, Inc.
SDGR 26.27 (05.10.2022) -0.42 %
Senseonics Holdings, Inc.
SENS 1.34 (05.10.2022) 0.00 %
Sorrento Therapeutics, Inc.
SRNE 1.61 (05.10.2022) -2.42 %
Stryker Corp.
SYK 216.12 (05.10.2022) 0.15 %
Sundial Growers Inc.
SNDL 2.26 (05.10.2022) -1.74 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.83 (04.10.2022) 7.29 %
Thermo Fisher Scientific Inc.
TMO 546.27 (05.10.2022) 1.17 %
Tilray, Inc.
TLRY 2.98 (05.10.2022) -0.67 %
UnitedHealth Group, Inc.
UNH 527.07 (05.10.2022) 0.75 %
Veeva Systems Inc.
VEEV 172.37 (05.10.2022) -0.21 %
Zomedica Corp.
ZOM 0.2076 (05.10.2022) -1.61 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.7297 (05.10.2022) -3.99 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.